1. Introduction {#sec1}
===============

Resting heart rate (RHR) is a well-recognized marker of autonomic nervous system tone and has been found to be a significant correlate of blood pressure, increased body mass index, and metabolic disturbances in many studies; this association is particularly striking in patients with hypertension or diabetes \[[@B1]\]. Elevated resting heart rate has been demonstrated to be associated with type 2 diabetes \[[@B2]\], metabolic syndrome \[[@B3], [@B4]\], cardiovascular disease, and all-cause mortality \[[@B5], [@B6]\].

The kidney is one of the important target organs of metabolic diseases. Chronic kidney disease (CKD), primarily caused by hypertension and diabetes \[[@B7]\], which could exacerbate or usually recurs and leads to impairment of renal function, increased risk of cardiovascular disease, cognitive disorders, anemia, and abnormal bone metabolism with untimely diagnosis and treatment. Urinary microalbumin is one of the sensitive indicators reflecting early renal function injury \[[@B8]\]. Many studies have reported that albuminuria is not only an independent risk factor of cardiovascular and cerebral diseases but also a relevant factor for stroke and cardiac cerebrovascular death \[[@B9]--[@B11]\].

A raised RHR has been found to be an independent predictor for the prevalence of microalbuminuria in hypertensive patients with high cardiovascular risk \[[@B12]\]. And people with type 2 diabetes mellitus who have a higher resting heart rate experience a greater incidence of new-onset or progressive nephropathy and retinopathy \[[@B13]\]. It has been shown that antihypertensive therapies are able to reduce the incidence of microalbuminuria, with blockers of the renin-angiotensin system being particularly effective \[[@B14], [@B15]\]. Furthermore, it was shown that a pharmacologically induced reduction in HR resulted in improvements of endothelial function in mice \[[@B16]\] and thus has the potential to reduce new-onset microalbuminuria in humans. The mechanism by which RHR affects the occurrence of microalbuminuria in diabetic patients remains unclear; it is likely that a combination of factors contributes to its development. Increases in pulse waves, glomerular pressure, base membrane permeability, inflammatory effects, and proatherosclerotic activity have been postulated to be involved in the process \[[@B12], [@B13], [@B17]\].

An early subanalysis of the randomized olmesartan and diabetes microalbuminuria prevention (ROADMAP) study on patients with type 2 diabetes has shown that a lower RHR was associated with a reduced risk of developing microalbuminuria, indicating that a lower RHR is an independent predictor for a lower risk of new-onset microalbuminuria in type 2 diabetes \[[@B18]\]. Our study extended the subjects to the general population, trying to explore the association between RHR and urinary albumin/creatinine ratio (UACR) at diverse blood pressure and blood glucose levels in general population from 8 different regional community cohorts in China.

2. Methods {#sec2}
==========

2.1. Study Population {#sec2.1}
---------------------

A total of 53,639 participants from the Risk Evaluation of cAncers in Chinese diabeTic Individuals a lONgitudinal (REACTION) study gave written informed consent, and the protocols were reviewed and approved by the research ethics committee at each of the participating centers (Dalian 10,140, Lanzhou 10,026, Guangzhou 9743, Luzhou 8105, Shanghai 6821, Guangxi 5831, Zhengzhou 1978, Wuhan 995). After excluding the subjects with primary kidney disease, heart disease, tumor history, related drug application, and important data loss, 32,885 participants were investigated.

2.2. Data Collection {#sec2.2}
--------------------

The baseline data were collected by trained health workers via a standardized questionnaire during interviews, including the general situation, the past medical history, the current medication situation, lifestyle, physical exercise, smoking and drinking habits, family history, and other basic information. All involved investigators have been formally trained. Participants were asked to take off shoes, hats, and coats before measurements. Waist circumference (WC) was measured at the horizontal level of the midpoint of the ligature between anterior superior spine and inferior margin of the twelfth rib. Hip circumference (HC) was defined as the horizontal of the most protruding part of the hip. Body mass index (BMI) = weight (kg)/\[height(m)\]^2^.

An automated electronic device (OMRON Model HEM-725 FUZZY, Omron Company, Dalian, China) was used to measure blood pressure and resting heart rate in the nondominant arm of seated participants three times consecutively at 1-minute intervals after a ≥5-minute rest. The three readings were averaged for analysis. The subjects were stratified based on RHR quartiles (Q1: RHR ≤ 71, Q2: 72 ≤ RHR ≤ 78, Q3: 79 ≤ RHR ≤ 86, and Q4: 87 ≤ RHR).

Urine samples were collected in the morning (midclean urine) for UACR measurements. Because the kits for measuring UACR in each center and the range of normal values are different, the value of UACR, divided by quartiles of all data in the center which the subject belonged to, was used to estimate albuminuria.

Blood samples were drawn in the morning after subjects had an 8-hour fasting the previous night. Participants without a history of diabetes underwent a 75 g oral glucose tolerance test, and their venous blood samples were drawn at 0 and 120 minutes. Biochemical index included triglyceride (TG), cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), creatinine (Cr), alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transaminase (GGT), fasting plasma glucose (FPG), postprandial plasma glucose (PPG), glycosylated hemoglobin (HbA1c), and fasting blood insulin was measured by the glucose oxidase-peroxidase method.

The estimated glomerular filtration rate (eGFR) was expressed in mL/min per 1.73 m^2^ by the formula eGFR = 186 × \[serum creatinine × 0.011\]‐1.154 × \[age\]‐0.203 × \[0.742 if female\] × 1.233, where serum creatinine was expressed as *μ*mol/L and 1.233 was the adjusting coefficient for the Chinese population. This formula is according to the abbreviated Modification of Diet in Renal Disease (MDRD), which was recalibrated for Chinese population.

2.3. Blood Glucose (mmol/L) and Blood Pressure (mmHg) {#sec2.3}
-----------------------------------------------------

Normal glucose tolerance (NGT) was defined as FPG \< 6.1 and PPG \< 7.8; impaired glucose regulation (IGR) was defined as 6.1 ≤ FPG \< 7.0 and/or 7.8 ≤ PPG \< 11.1; diabetes mellitus (DM) was defined as FPG ≥ 7.8 and/or PPG ≥ 11.1. Normal blood pressure (NBP) was defined as 90 ≤ systolic blood pressure (SBP) \< 140 and 60 ≤ diastolic blood pressure (DBP) \< 90; hypertension was defined as SBP ≥ 140 and/or DBP ≥ 90.

2.4. Statistical Analysis {#sec2.4}
-------------------------

The data was analyzed by SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL, USA). The normality of distribution of continuous variables was tested by the one-sample Kolmogorov-Smirnov test. Continuous variables with normal distribution were presented as mean ± standard deviation (SD). The Mann-Whitney *U* test and the Kruskal-Wallis test were used, respectively, to compare the means of 2 and 3 or more groups of variables not normally distributed. The frequencies of categorical variables were compared using Pearson Chi-square or Fisher\'s exact test, when appropriate. A value of *P* \< 0.05 was considered significant. Ordinary logistic regression was performed to explore the association between RHR and UACR.

3. Results {#sec3}
==========

3.1. Clinical Characteristics of the Study Population {#sec3.1}
-----------------------------------------------------

A total of 32,885 participants, including 10,058 males and 22,827 females were accepted into the study. The general clinical characteristics of the study population are presented in [Table 1](#tab1){ref-type="table"}. The subjects with the higher RHR were more likely to have higher DBP, FPG, PPG, HbA1c, insulin, TC, TG, LDL, ALT, AST, and GGT (*P* \< 0.001). The means of age, HC, SBP, Cr, and eGFR have a significant difference between RHR quartiles. The percentile of UACR \> 75% is higher in the higher RHR group as [Figure 1](#fig1){ref-type="fig"} shows.

3.2. Statistical Analysis {#sec3.2}
-------------------------

Multiple factor analysis was carried out to screen out the risk factors related to UACR. [Table 2](#tab2){ref-type="table"} shows that RHR, gender, blood pressure, and blood glucose are significantly associated with UACR (all *P* \< 0.05). Ordinal logistic regression was performed to explore the association between UACR and RHR. [Table 3](#tab3){ref-type="table"} presents the results. There was a positive relationship between RHR and UACR (all *P* \< 0.05). After adjusted for gender, age, BMI, WC, smoking, and alcohol drinking, the risk of having UACR increased progressively across the lowest to the highest quartiles of RHR with ORs of 1.07 (95% CI 1.01-1.13), 1.18 (95% CI 1.12-1.25), and 1.33 (95% CI 1.26-1.41), respectively (all *P* \< 0.05). When adjusted for all factors, the third quartile (OR: 1.13; 95% CI 1.07-1.20) and the fourth quartile (OR: 1.17; 95% CI 1.10-1.24) still tend to have a higher UACR.

3.3. Stratification according to Blood Pressure and Blood Glucose {#sec3.3}
-----------------------------------------------------------------

The association between UACR and RHR at diverse blood pressure and blood glucose was analyzed by ordinal logistic regression. As [Table 4](#tab4){ref-type="table"} shows, in the nonhypertension group, the risk of higher UACR occurrence in the third quartile (OR: 1.11; 95% CI 1.04-1.18) and the fourth quartile (OR: 1.22; 95% CI 1.13-1.31) increased when compared to the first quartile; in the hypertension group, the positive relationship disappeared. As to the blood glucose level, in the normal glucose group, the risk of having UACR in the second quartile (OR: 1.07; 95% CI 1.00-1.15), third quartile (OR: 1.13; 95% CI 1.05-1.21), and fourth quartile (OR: 1.19; 95% CI 1.10-1.29) increased when compared to the first quartile, while in the impaired glucose regulation group and the diabetes mellitus group, we cannot observe the positive relationship.

4. Discussion {#sec4}
=============

Chronic kidney disease has insidious onset and slow progression and is easy to be ignored. UACR is a sensitive indicator reflecting early renal function injury. Resting heart rate is a reliable indicator of sympathetic nervous system excitation, and epidemiological studies \[[@B19], [@B20]\] show that resting heart rate increases are closely related to the risk of hypertension, diabetes, and other diseases. The present study demonstrated the association between the RHR and the UACR level in general population from 8 regional centers of Chinese mainland. We found that there was a positive relationship between RHR and UACR. Compared to Q1 (RHR ≤ 71), the risk of UACR in the subjects belong to Q3 (79 ≤ RHR ≤ 86) and Q4 (87 ≤ RHR) increased, respectively, by 13% (OR: 1.13) and 17% (OR: 1.17), even after adjusting confounding factors such as gender, age, BMI, WC, smoking, alcohol drinking, blood pressure, blood glucose, ALT, AST, GGT, TC, TG, HDL-c, and LDL-c.

A previous study in Germany that included 4447 patients with type 2 diabetes showed that as the heart rate increases, the risk of microalbuminuria appearing increased \[[@B18]\]; this positive relationship is in accordance with our study. This indicates that lowering the resting heart rate may be a protective factor against microalbuminuria. However, the difference is that the study population in Germany is limited to patients with type 2 diabetes. In our study, we excluded the diagnosed diabetes case when we stratified the subjects according to blood glucose. In the normal glucose tolerance population, compared with Q1 (RHR ≤ 71), the risk of albuminuria in the subjects belong to Q3 (79 ≤ RHR ≤ 86) and Q4 (87 ≤ RHR) increased by 13% (OR: 1.13) and 19% (OR: 1.19), respectively, while in the impaired glucose regulation or diabetes mellitus population, the relationship disappeared. The hypoglycemic therapy and the course of diabetes may cause the difference between two studies.

There was also a study extending the previous findings to a population with cardiovascular disease, showing that heart rate is associated with a renal disease risk and suggesting that a reduction in heart rate might be protective for kidney function \[[@B21]\]. In this study, we included the general population (excluding the subject who was diagnosed with cardiovascular disease, kidney disease, tumor history, and related drug application), stratifying the population according to blood pressure. Results showed that in the nonhypertension group, subjects in the Q3 (78 ≤ RHR ≤ 86) quartile and the Q4 (87 ≤ RHR) quartile tend to have a higher UACR; ORs were 1.11 and 1.22, respectively; in the hypertension group, the relationship was of no significance. Perhaps, the effect of hypertension on UACR covered the association between RHR and UACR.

Our study shows that hypertension (OR: 1.66) and diabetes (OR: 1.52) are more significant than RHR (the highest group compared to the lowest group, OR: 1.17) related to UACR. In the general population, the positive relationship between RHR and UACR exists, while in the new diagnostic hypertension and diabetes group, it disappeared. In combination with previous results, we may guess that after effective hypoglycemic and antihypertensive therapy, the relationship between RHR and UACR will reoccur, but it remains further clinical trials. Anyhow, RHR may be a marker of UACR, which reflects early renal impairment.

Several mechanisms may underlie these effects such as progression of atherosclerosis, and thus nephrosclerosis, due to changes in endothelial oxidative stress, which is sensitive to RHR reduction \[[@B16], [@B22]\]. Furthermore, RHR is associated with increased aortic stiffness, which in turn is linked to cardiovascular disease outcomes such as stroke, coronary events, and heart failure \[[@B23]--[@B26]\]. An increased RHR appears to be associated with microvascular disease in general and also with complications of renal failure \[[@B27], [@B28]\]. In addition, several studies show that an increased RHR can not only increase tensile stress, causing endothelial cell injury, but also increase the permeability of endothelial cells to circulating inflammatory mediators, thus mediated the progression of microalbuminuria \[[@B22], [@B29]\]. In the kidney, myogenic autoregulation, that is, vasoconstriction of the afferent arteriole in response to high perfusion pressures to prevent hyperperfusion, is impaired in hypertension, ageing, and diabetes, making the kidney more prone to pulsatile stress \[[@B30]--[@B34]\]. To date, direct experimental data on heart rate or studies providing information on the relevance of RHR in humans have been lacking. However, it has been reported that increased RHR could also be a sign of increased sympathetic activation \[[@B35]\] and increased sympathetic activation has been observed in patients with renal failure \[[@B36]\]. Besides being a generator of sympathetic activity, the kidney also acts as recipient of efferent signals. Increased renal sympathetic activity leads to a cascade of actions: by stimulating the release of renin by the juxtaglomerular cells, angiotensin II is produced. Angiotensin II directly causes vasoconstriction; renal blood flow and glomerular filtration rate decrease by renal vasoconstriction. This is further amplified by direct activation of the RAS by kidney injury. Increases in renal sympathetic nerve activity also directly increase renal tubular sodium reabsorption \[[@B37]\].

Participants in our study belonged to 8 communities of mainland China, guaranteeing representative results. Compared to other studies, our participants included diverse blood pressure and blood glucose (after excluding the effects of related drugs). Therefore, we fully adjusted confounding such as gender, age, BMI, WC, liver function, and serum lipid. However, several deficiencies exist in this study. First, protein content intake in the previous day and the interval between last meal and sleep were not available; second, UACR levels were determined by a single measurement, but detection methods of the 8 centers were different; third, this is a cross-sectional study; we cannot get a cause-and-effect relationship. Its specific mechanism needs to be explored and confirmed by further basic experiments, but the conclusion still has a certain clinical sense in some aspect.

5. Conclusion {#sec5}
=============

Our study reported the association between RHR and UACR in general population. For the population with nonhypertension and normal glucose tolerance, higher RHR is associated with higher UACR. As for the population with hypertension and diabetes, the positive relationship disappeared. After adjusting blood pressure and blood glucose, people with higher RHR tend to have a higher UACR. That indicates RHR may represent an independent risk factor for chronic kidney disease.
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###### 

Participants\' characteristics according to resting heart rate quartiles.

  Variable                  RHR quartile (beat/min)   *P* value                                 
  ------------------------- ------------------------- ------------- ------------- ------------- ---------
  Gender                    8185                      8658          8386          7658          
   Male                     2890 (35.3)               2501 (28.9)   2387 (28.5)   2280 (29.7)   
   Female                   5295 (64.7)               6157 (71.1)   5999 (71.5)   5376 (70.3)   
  Age (year)                57.1 ± 8.6                56.4 ± 8.8    56.1 ± 8.9    56.5 ± 9.4    
  BMI (kg/m^2^)             24.2 ± 3.5                24.3 ± 3.6    24.2 ± 3.5    24.2 ± 3.8    0.337
  WC (cm)                   84.7 ± 9.8                84.6 ± 9.8    84.4 ± 9.9    84.3 ± 10.4   0.075
  HC (cm)                   96.2 ± 7.6                96.2 ± 7.9    95.9 ± 7.7    95.8 ± 8.1    0.001
  WC/HC                                                                                         0.656
  Smoking                                                                                       \<0.001
   Current                  1180 (14.4)               1002 (11.6)   967 (11.5)    873 (11.4)    
   Former                   464 (5.7)                 361 (4.2)     352 (4.2)     327 (4.3)     
   Never                    6541 (79.9)               7295 (84.3)   7067 (84.3)   6456 (84.3)   
  Alcohol drinking                                                                              \<0.001
   Current                  660 (8.1)                 558 (6.4)     577 (6.9)     512 (6.7)     
   Former                   183 (2.2)                 147 (1.7)     150 (1.8)     127 (1.7)     
   Never                    7342 (89.7)               7953 (91.9)   7659 (91.3)   7017 (91.5)   
  SBP (mmHg)                127 ± 19                  127 ± 19      127 ± 19      131 ± 20      \<0.001
  DBP (mmHg)                74 ± 10                   75 ± 10       77 ± 10       80 ± 11       \<0.001
  FPG (mmol/L)              5.53 ± 1.06               5.60 ± 1.16   5.72 ± 1.35   5.95 ± 1.60   \<0.001
  PPG (mmol/L)              7.28 ± 2.86               7.51 ± 2.85   7.89 ± 3.31   8.42 ± 3.72   \<0.001
  HbA1c (%)                 5.85 ± 0.67               5.87 ± 0.71   5.92 ± 0.85   5.98 ± 1.01   \<0.001
  Insulin (*μ*U/mL)         7.28 ± 6.37               7.76 ± 4.13   8.06 ± 5.23   8.70 ± 4.94   \<0.001
  TC (mmol/L)               4.89 ± 1.14               4.95 ± 1.18   5.04 ± 1.19   5.09 ± 1.25   \<0.001
  TG (mmol/L)               1.44 ± 1.01               1.51 ± 1.07   1.61 ± 1.20   1.69 ± 1.29   \<0.001
  HDL-c (mmol/L)            1.31 ± 0.35               1.32 ± 0.35   1.33 ± 0.36   1.33 ± 0.36   0.079
  LDL-c (mmol/L)            2.88 ± 0.88               2.91 ± 0.91   2.95 ± 0.91   2.99 ± 0.95   \<0.001
  ALT (mmol/L)              17.1 ± 11.8               17.4 ± 13.3   17.6 ± 13.4   18.6 ± 15.3   \<0.001
  AST (mmol/L)              21.2 ± 9.2                21.3 ± 11.7   21.4 ± 10.6   22.4 ± 13.5   \<0.001
  GGT (mmol/L)              25.8 ± 26.4               26.2 ± 30.2   28.1 ± 31.8   32.6 ± 51.6   \<0.001
  Cr (*μ*mol/L)             67.6 ± 18.8               65.8 ± 14.0   66.3 ± 14.2   67.3 ± 15.0   \<0.001
  eGFR (mL/min/1.73 m^2^)   96.5 ± 20.8               97.7 ± 21.3   96.7 ± 20.2   95.9 ± 21.9   \<0.001
  UACR                                                                                          \<0.001
   ≤25%                     2273 (27.8)               2263 (26.1)   2045 (24.4)   1647 (21.5)   
   25%-50%                  2067 (25.3)               2176 (25.1)   2057 (24.5)   1916 (25.0)   
   50%-75%                  2008 (24.5)               2129 (24.6)   2134 (25.4)   1947 (25.4)   
   \>75%                    1837 (22.4)               2090 (24.1)   2120 (25.6)   2146 (28.0)   

The values are presented as the means ± the standard deviations or the numbers (percentage).

###### 

Multiple factors related to UACR.

                                        OR (95% CI)         *P*
  ----------------- ------------------- ------------------- ---------
  HR                Q1 (≤71)                                
  Q2 (72-78)        1.05 (0.99, 1.11)   0.101               
  Q3 (79-86)        1.13 (1.07, 1.20)   \<0.001             
  Q4 (≥87)          1.17 (1.10, 1.24)   \<0.001             
                                                            
  Gender            Man                 0.48 (0.45, 0.50)   \<0.001
  Woman                                                     
                                                            
  Blood pressure    Hypertension        1.66 (1.59, 1.75)   \<0.001
  Nonhypertension                                           
                                                            
  Blood glucose     DM                  1.52 (1.43, 1.63)   \<0.001
  IGR               1.06 (1.01, 1.12)   0.012               
  NGT                                                       
                                                            
  Age                                   1.03 (1.02, 1.03)   \<0.001
                                                            
  WC                                    1.50 (1.13, 2.00)   0.005
                                                            
  TG                                    1.05 (1.03, 1.07)   \<0.001
                                                            
  Cr                                    0.99 (0.99, 1.00)   \<0.001
                                                            
  ALT                                   1.00 (0.99, 1.00)   0.002
                                                            
  AST                                   1.00 (1.00, 1.01)   0.006
                                                            
  GGT                                   1.00 (1.00, 1.00)   \<0.001

###### 

Relationship between RHR and UACR in total participants.

            Q1   Q2                  *P*     Q3                  *P*       Q4                  *P*
  --------- ---- ------------------- ------- ------------------- --------- ------------------- ---------
  Model 1   1    1.08 (1.03, 1.15)   0.003   1.19 (1.12, 1.25)   \<0.001   1.34 (1.27, 1.42)   \<0.001
  Model 2   1    1.07 (1.01, 1.13)   0.015   1.18 (1.12, 1.25)   \<0.001   1.33 (1.26, 1.41)   \<0.001
  Model 3   1    1.05 (1.00, 1.12)   0.065   1.16 (1.10, 1.23)   \<0.001   1.27 (1.20, 1.35)   \<0.001
  Model 4   1    1.05 (0.99, 1.11)   0.101   1.13 (1.07, 1.20)   \<0.001   1.17 (1.10, 1.24)   \<0.001

Model 1: unadjusted. Model 2: adjusted for gender, age, BMI, WC, smoking, and alcohol drinking. Model 3: further adjusted for ALT, AST, GGT, TC, TG, HDL-c, and LDL-c. Model 4: further adjusted for SBP, DBP, FPG, and PPG.

###### 

Relationship between RHR and UACR at diverse BP and BG levels.

                    Variable       Q1                  Q2                  *P*                 Q3                  *P*                 Q4                  *P*
  ----------------- -------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- -------
  BP                Hypertension   1                   1.08 (0.96, 1.21)   0.197               1.20 (1.07, 1.34)   0.002               1.09(0.98, 1.22)    0.129
  Nonhypertension   1              1.04 (0.97, 1.11)   0.281               1.11 (1.04, 1.18)   0.003               1.22 (1.13, 1.31)   \<0.001             
                                                                                                                                                           
  BG                DM             1                   1.04 (0.88, 1.24)   0.631               1.22 (1.03, 1.44)   0.021               1.16 (0.98, 1.36)   0.077
  IGR               1              0.99 (0.88, 1.11)   0.846               1.09 (0.98, 1.22)   0.123               1.14 (1.02, 1.28)   0.020               
  NGT               1              1.07 (1.00, 1.15)   0.052               1.13 (1.05, 1.21)   0.002               1.19 (1.10, 1.29)   \<0.001             

BP: blood pressure; NBP: normal blood pressure; BG: blood glucose; NGT: normal glucose tolerance; IGR: impaired glucose regulation; DM: diabetes mellitus.
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